These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38412033)

  • 1. Exploring Factors That Influence Postexercise Glycemia in Youth With Type 1 Diabetes in the Real World: The Type 1 Diabetes Exercise Initiative Pediatric (T1DEXIP) Study.
    Sherr JL; Bergford S; Gal RL; Clements MA; Patton SR; Calhoun P; Beaulieu LC; Riddell MC
    Diabetes Care; 2024 May; 47(5):849-857. PubMed ID: 38412033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Acute Effects of Real-World Physical Activity on Glycemia in Adolescents With Type 1 Diabetes: The Type 1 Diabetes Exercise Initiative Pediatric (T1DEXIP) Study.
    Riddell MC; Gal RL; Bergford S; Patton SR; Clements MA; Calhoun P; Beaulieu LC; Sherr JL
    Diabetes Care; 2024 Jan; 47(1):132-139. PubMed ID: 37922335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examining the Acute Glycemic Effects of Different Types of Structured Exercise Sessions in Type 1 Diabetes in a Real-World Setting: The Type 1 Diabetes and Exercise Initiative (T1DEXI).
    Riddell MC; Li Z; Gal RL; Calhoun P; Jacobs PG; Clements MA; Martin CK; Doyle Iii FJ; Patton SR; Castle JR; Gillingham MB; Beck RW; Rickels MR;
    Diabetes Care; 2023 Apr; 46(4):704-713. PubMed ID: 36795053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with nocturnal hypoglycemia in at-risk adolescents and young adults with type 1 diabetes.
    Wilson DM; Calhoun PM; Maahs DM; Chase HP; Messer L; Buckingham BA; Aye T; Clinton PK; Hramiak I; Kollman C; Beck RW;
    Diabetes Technol Ther; 2015 Jun; 17(6):385-91. PubMed ID: 25761202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large pre- and postexercise rapid-acting insulin reductions preserve glycemia and prevent early- but not late-onset hypoglycemia in patients with type 1 diabetes.
    Campbell MD; Walker M; Trenell MI; Jakovljevic DG; Stevenson EJ; Bracken RM; Bain SC; West DJ
    Diabetes Care; 2013 Aug; 36(8):2217-24. PubMed ID: 23514728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of algorithm-based modifications of insulinotherapy during exercise in MDI vs insulin pump-treated children with type 1 diabetes: Results from the TREAD-DIAB study.
    Moniotte S; Owen M; Barrea T; Robert A; Lysy PA
    Pediatr Diabetes; 2017 Dec; 18(8):925-933. PubMed ID: 28251726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes.
    Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
    Diabetes Care; 2010 May; 33(5):1004-8. PubMed ID: 20200306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lag Time Remains with Newer Real-Time Continuous Glucose Monitoring Technology During Aerobic Exercise in Adults Living with Type 1 Diabetes.
    Zaharieva DP; Turksoy K; McGaugh SM; Pooni R; Vienneau T; Ly T; Riddell MC
    Diabetes Technol Ther; 2019 Jun; 21(6):313-321. PubMed ID: 31059282
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of Nocturnal Glucose After Exercise Among Dual-Hormone, Single-Hormone Algorithm-Assisted Insulin Delivery System and Usual Care in Adults and Adolescents Living with Type 1 Diabetes: A Pooled Analysis.
    Wu Z; Yardley JE; Messier V; Legault L; Grou C; Rabasa-Lhoret R
    Diabetes Technol Ther; 2022 Oct; 24(10):754-762. PubMed ID: 35653732
    [No Abstract]   [Full Text] [Related]  

  • 10. Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial.
    Messer LH; Buckingham BA; Cogen F; Daniels M; Forlenza G; Jafri RZ; Mauras N; Muir A; Wadwa RP; White PC; Russell SJ; Damiano ER; El-Khatib FH; Ruedy KJ; Balliro CA; Li Z; Marak MC; Calhoun P; Beck RW
    Diabetes Technol Ther; 2022 Oct; 24(10):712-725. PubMed ID: 36173237
    [No Abstract]   [Full Text] [Related]  

  • 11. "Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.
    Biester T; Kordonouri O; Holder M; Remus K; Kieninger-Baum D; Wadien T; Danne T
    Diabetes Technol Ther; 2017 Mar; 19(3):173-182. PubMed ID: 28099035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avoiding hypoglycemia: the use of insulin pump combined with continuous glucose monitor in type 1 diabetes crossing a Rocky Gorge.
    Thomakos P; Vazeou A; Sakkas D; Panagopoulos G; Anifantakis K; Smyrnaki P; Arvanitaki T; Kyrlaki E; Kefalogiannis N; Mamoulakis D; Pappas A; Mitrakou A
    QJM; 2018 Sep; 111(9):629-633. PubMed ID: 29939323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous Blood Glucose Monitoring Increases Vigorous Physical Activity Levels and Is Associated With Reduced Hypoglycemia Avoidance Behavior In Youth With Type 1 Diabetes.
    Jabbour G; Bragazzi NL
    Front Endocrinol (Lausanne); 2021; 12():722123. PubMed ID: 34557162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with glycemic variability in children with type 1 diabetes mellitus based on flash glucose monitoring system.
    Zhang L; Guo K; Xu Y; Bai J; Ma Y; Fu L; Liu J; Hu K; Li X; Jiang H; Yang L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 47(4):462-468. PubMed ID: 35545341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower Glycated Hemoglobin with Real-Time Continuous Glucose Monitoring Than with Intermittently Scanned Continuous Glucose Monitoring After 1 Year: The CORRIDA LIFE Study.
    Radovnická L; Hásková A; Do QD; Horová E; Navrátilová V; Mikeš O; Cihlář D; Parkin CG; Grunberger G; Prázný M; Šoupal J
    Diabetes Technol Ther; 2022 Dec; 24(12):859-867. PubMed ID: 36037056
    [No Abstract]   [Full Text] [Related]  

  • 17. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are nocturnal hypoglycemia prevention strategies influenced by diabetes technology usage? A BETTER registry analysis.
    Talbo MK; Rabasa-Lhoret R; Yale JF; Peters TM; Brazeau AS
    Diabetes Res Clin Pract; 2022 Sep; 191():110080. PubMed ID: 36099973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between daily step count classifications and continuous glucose monitoring metrics in adults with type 1 diabetes: analysis of the Type 1 Diabetes Exercise Initiative (T1DEXI) cohort.
    Turner LV; Marak MC; Gal RL; Calhoun P; Li Z; Jacobs PG; Clements MA; Martin CK; Doyle FJ; Patton SR; Castle JR; Gillingham MB; Beck RW; Rickels MR; Riddell MC;
    Diabetologia; 2024 Jun; 67(6):1009-1022. PubMed ID: 38502241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of accelerometer use in exercise-associated hypoglycemia prevention in type 1 diabetes.
    Stenerson M; Cameron F; Payne SR; Payne SL; Ly TT; Wilson DM; Buckingham BA
    J Diabetes Sci Technol; 2015 Jan; 9(1):80-5. PubMed ID: 25231116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.